Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sofosbuvir Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106188193A reveals a novel N-protection strategy for Sofosbuvir intermediates, ensuring high purity, reduced impurities, and scalable manufacturing for global supply chains.
Patent CN107245064A details safer borohydride reduction for Sofosbuvir intermediates. Achieve high purity and cost reduction in API manufacturing with scalable recovery methods.
Patent CN111848554B details a high-purity synthesis route for sofosbuvir intermediate impurity KD003, offering enhanced supply chain reliability and cost-effective manufacturing solutions.
Advanced synthetic route for Sofosbuvir impurities using orthogonal protection strategies. Ensures high purity reference standards for pharmaceutical quality control and regulatory compliance.